| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/31/2006 | CN1257720C Capsule of Chinese traditional medicine for treating thrombus |
| 05/31/2006 | CN1257713C Flunarizine hydrochloride injection and its preparing method |
| 05/31/2006 | CN1257710C Preparation made from effective position of red sage root, and its preparation method |
| 05/31/2006 | CN1257709C Tensicor freeze-drying formulation and its making method |
| 05/30/2006 | US7053230 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053123 Substituted (e)-styryl benzylsulfones for treating proliferative disorders |
| 05/30/2006 | US7053116 Contacting cells with phenyl benzopyranone compound or or enantiomers, diastereomeric isomers or mixtures of any two or more thereof, or pharmaceutically acceptable salts thereof for blocking amyloid toxicity in cells |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
| 05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053099 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053094 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/30/2006 | US7053087 Aminocycloalkyl cinnamide compounds for arrhythmia and analgesics and anesthetics |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053083 Medicine for inducing temporary delay of urination or treatment of disorders of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or bleeding and coagulation disorders |
| 05/30/2006 | US7053070 Antiproliferative agents; anticarcinogenic agents; viricides |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053049 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 05/30/2006 | US7053047 Cyclic pentapeptides and their preparation |
| 05/30/2006 | US7052862 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/30/2006 | CA2321380C 6-azauracil derivatives as thyroid receptor ligands |
| 05/30/2006 | CA2251132C Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents |
| 05/30/2006 | CA2141692C Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/30/2006 | CA2106613C Benzoylguanidines, process for their preparation, their use as a medicament and medicament containing them |
| 05/30/2006 | CA2085831C Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals |
| 05/26/2006 | WO2006055747A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | WO2006055597A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | WO2006055573A2 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 05/26/2006 | WO2006055526A2 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/26/2006 | WO2006055216A2 Vulnerable plaque treatment |
| 05/26/2006 | WO2006054912A1 Aryl(hetaryl)-3-aminomethyl-quinilone-2 derivatives in the form of no-synthetase i and cyclooxygenase-2 nhibitors, methods for the production thereof and compositions based thereon |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054691A1 Soluble protein and utilization of the same |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054319A2 Use of chitooligomer formulations to modify abnormal activity of chitinase like proteins |
| 05/26/2006 | WO2006053754A1 COMBINATIONS OF ANTI-ATHEROSCLEROTIC PEPTIDES AND AN mTOR INHIBITING AGENT AND THEIR METHODS OF USE |
| 05/26/2006 | WO2006053748A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | WO2006053379A1 Improved nutraceutical composition |
| 05/26/2006 | WO2006031786A3 Protein a compositions and methods of use |
| 05/26/2006 | WO2006029179A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 05/26/2006 | WO2006027052A3 (halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators |
| 05/26/2006 | WO2006022901A3 The use of purine nucleosides to stimulate na/k atpase and to treat or prevent shock |
| 05/26/2006 | WO2006005415A3 Use of l-carnitine and glucose for the treatment of cardiovascular diseases |
| 05/26/2006 | WO2005120518A3 Use of atp analogues for treatment of cardiovascular diseases |
| 05/26/2006 | WO2005075022A3 Susceptibility gene for myocardial infraction, stroke, and paod; methods of treatment |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2588066A1 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 05/26/2006 | CA2587616A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | CA2587598A1 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases |
| 05/26/2006 | CA2587499A1 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 05/26/2006 | CA2587391A1 Compositions useful to treat ocular neovascular diseases and macular degeneration |
| 05/26/2006 | CA2585581A1 Enhancing treatment of hif-1 mediated disorders with adenosine a3 receptor agonists |
| 05/25/2006 | WO2006029577A9 Methods and compositions for the treatment of hyperlipidemia |
| 05/25/2006 | US20060111607 Cardiac support with metallic structure |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111445 Novel carboxylic acids and derivatives for the treatment of and preventing diabetes and dyslipidaemia |
| 05/25/2006 | US20060111444 Novel halogen-substituted aminodicarboxylic acid derivatives |
| 05/25/2006 | US20060111424 Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |
| 05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
| 05/25/2006 | US20060111406 Amide linker peroxisome proliferator activated receptor modulators |
| 05/25/2006 | US20060111400 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111390 Azaindoles as inhibitors of c-jun n-terminal kinases |
| 05/25/2006 | US20060111377 Heterocyclic derivatives |
| 05/25/2006 | US20060111375 Compound having tgfß inhibitory activity and medicinal composition containing the same |
| 05/25/2006 | US20060111374 N-(3-amino-propyl)-N-[1-(3-benzyl-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl)-2-methyl-propyl]-4-methyl-benzamide; kinesin spindle protein inhibitor; cell division, mitosis phase arrest; antiproliferative and antiinflammation agent, hyperplasias, restenosis, cardiac hypertrophy, autoimmune disorders |
| 05/25/2006 | US20060111368 Phosphodiesterase inhibitor |
| 05/25/2006 | US20060111362 1,3-Dihydroimidazole ring compound |
| 05/25/2006 | US20060111341 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 05/25/2006 | US20060111340 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/25/2006 | US20060111290 Stromal-Derived Factor-1 (SDF), G-CSF (granulocyte-colony stimulating factor), stimulating vasculogenesis; improves cardiac function |
| 05/25/2006 | US20060111286 Method of modulating endothelial cell activity |
| 05/25/2006 | US20060110473 Composition containing radix codonopsis pilosulae and radix astragali and hedysari, method of producing it and use thereof |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110384 Novel proteins and use thereof |
| 05/25/2006 | US20060110382 For treating a disease medicated by TNF alpha including acute and chronic immune and immunoregulatory disorders and rheumatoid or osteo-arthritis |
| 05/25/2006 | US20060110368 Medium for culturing autologous human progenitor stem cells and applications thereof |
| 05/25/2006 | US20060110362 Sequences upstream of the CARP gene, vectors containing them and uses thereof |
| 05/24/2006 | EP1659121A1 1,3-dihydro-2h-indol-2-one derivative |
| 05/24/2006 | EP1659120A1 3-substituted quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists |
| 05/24/2006 | EP1659114A2 Process for the preparation of bicyclo[3.2.1]octane fused with quinazoline derivatives |
| 05/24/2006 | EP1658879A1 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases |
| 05/24/2006 | EP1658849A2 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 05/24/2006 | EP1658312A1 Modulators of the potassium channels twik-1, task-1, girk1, sk2 or pcn1, used to treat arrhythmia, coronary heart disease or hypertension |
| 05/24/2006 | EP1658266A1 Pentafluorosulfanyl phenyl-substituted benzoylguanidines, method for their production, their use as medicaments or diagnostic agents and medicament containing said compounds |
| 05/24/2006 | EP1658260A1 Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes |